Mowat-Wilson syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2152OMIM:235730Q43.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mowat-Wilson syndrome (MWS), also known as Mowat-Wilson syndrome due to ZEB2 deficiency or Hirschsprung disease–intellectual disability syndrome, is a rare genetic neurodevelopmental disorder caused by heterozygous loss-of-function mutations or deletions of the ZEB2 (also known as SIP1 or ZFHX1B) gene on chromosome 2q22. The condition affects multiple body systems and is characterized by a distinctive facial appearance (widely spaced eyes, broad nasal bridge, prominent rounded nasal tip, open mouth with M-shaped upper lip, and uplifted earlobes), moderate to severe intellectual disability, delayed motor development, and limited or absent speech. Seizures (epilepsy) occur in the majority of affected individuals, typically presenting in early childhood. Hirschsprung disease (aganglionosis of the colon) is a hallmark feature, present in approximately 50–60% of individuals with MWS, and is often the presenting clinical finding that leads to diagnosis. Other frequently associated anomalies include congenital heart defects (such as patent ductus arteriosus, ventricular septal defect, and pulmonary artery sling), urogenital anomalies (hypospadias, cryptorchidism, renal malformations), eye abnormalities (microphthalmia, coloboma, strabismus), and structural brain anomalies including agenesis or hypoplasia of the corpus callosum. Growth may be affected, with short stature observed in some patients. Individuals with MWS typically have a happy and sociable demeanor. There is no cure for Mowat-Wilson syndrome, and management is supportive and symptom-directed. Hirschsprung disease requires surgical intervention (pull-through procedure). Epilepsy is managed with antiepileptic medications, and congenital heart defects may require surgical correction. Speech therapy, physical therapy, occupational therapy, and special educational support are essential components of long-term care. Regular monitoring by a multidisciplinary team including neurology, cardiology, gastroenterology, urology, and ophthalmology is recommended.

Also known as:

Clinical phenotype terms— hover any for plain English:

Reduced social responsivenessHP:0012760Happy demeanorHP:0040082Renal duplicationHP:0000075Pelvic kidneyHP:0000125Retinal colobomaHP:0000480
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mowat-Wilson syndrome.

View clinical trials →

No actively recruiting trials found for Mowat-Wilson syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mowat-Wilson syndrome community →

No specialists are currently listed for Mowat-Wilson syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mowat-Wilson syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mowat-Wilson syndromeForum →

No community posts yet. Be the first to share your experience with Mowat-Wilson syndrome.

Start the conversation →

Latest news about Mowat-Wilson syndrome

No recent news articles for Mowat-Wilson syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mowat-Wilson syndrome

What is Mowat-Wilson syndrome?

Mowat-Wilson syndrome (MWS), also known as Mowat-Wilson syndrome due to ZEB2 deficiency or Hirschsprung disease–intellectual disability syndrome, is a rare genetic neurodevelopmental disorder caused by heterozygous loss-of-function mutations or deletions of the ZEB2 (also known as SIP1 or ZFHX1B) gene on chromosome 2q22. The condition affects multiple body systems and is characterized by a distinctive facial appearance (widely spaced eyes, broad nasal bridge, prominent rounded nasal tip, open mouth with M-shaped upper lip, and uplifted earlobes), moderate to severe intellectual disability, del

How is Mowat-Wilson syndrome inherited?

Mowat-Wilson syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mowat-Wilson syndrome typically begin?

Typical onset of Mowat-Wilson syndrome is neonatal. Age of onset can vary across affected individuals.